Human Papillomavirus 16-Type Detection and Genotyping Kit

A diagnostic test kit for the detection of human papillomavirus types 16 and 18 using PCR with fluorescence methodology. This kit is used to identify HPV infection status in clinical specimens.

Molecular detection kit for high-risk HPV types 16 and 18. Supports cervical cancer screening and risk stratification.

A molecular PCR test kit for the detection of human papillomavirus types 16 and 18. Used for cervical cancer risk assessment and screening.

In vitro qualitative detection kit for 18 types of high-risk HPV using fluorescence PCR technology. Suitable for urine, cervical swab, and vaginal swab samples with HPV 16/18 typing capability. CE and TFDA approved for clinical diagnostic use.

This kit is suitable for in vitro qualitative detection of 18 types of human papillomavirus (HPV 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, 82) specific nucleic acid fragments in human urine samples, female cervical swab samples, female vaginal swab samples, and HPV 16/18 typing.

This kit is suitable for in vitro qualitative detection of 17 types of human papillomavirus (HPV 6, 11, 16, 18, 31, 33, 35, 39, 44, 45, 51, 52, 56, 58, 59, 66, 68) specific nucleic acid fragments in urine samples, female cervical swab samples, and female vaginal swab samples, as well as HPV 16/18/6/11/44 typing detection.

A nucleic acid detection kit designed to identify 14 types of high-risk human papillomavirus (HPV) with specific genotyping for HPV types 16 and 18. This test kit enables comprehensive HPV screening and risk stratification for cervical cancer prevention. The kit provides detailed genotyping information for clinical management and patient counseling.

A diagnostic test kit detecting 18 types of human papillomavirus including 14 high-risk types recognized by WHO as causative agents of cervical cancer and 4 medium-risk types associated with cervical cancer, using hybrid capture-chemiluminescence method.

CE-IVD marked qPCR detection kit for identification of Human Papillomavirus types 16 and 18 in clinical samples. Enables rapid molecular diagnosis of high-risk HPV strains associated with cervical and anogenital cancers. Suitable for use in clinical laboratories and diagnostic facilities performing HPV screening and risk stratification.

This kit is suitable for in vitro qualitative detection of 28 types of human papillomavirus (HPV 6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53, 54, 56, 58, 59, 61, 66, 68, 73, 81, 82, 83) nucleic acids in clinical urine samples, female cervical swab samples, and female vaginal swab samples, as well as HPV 16/18/45 typing detection, while providing aid in the diagnosis and treatment of HPV infection.

A diagnostic test kit for the detection of human papillomavirus (HPV) nucleic acids. The kit detects 18 types of HPV including 14 high-risk types recognized by the WHO that can lead to cervical cancer, as well as 4 medium-risk types identified by authoritative research as potentially related to cervical cancer. It uses hybridization capture and chemiluminescence methodology.

PCR-based human papillomavirus detection assay capable of identifying 23 HPV genotypes including 18 high-risk and 5 low-risk variants for cervical cancer screening and auxiliary diagnosis.